×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

 

Modérateur : Pr Jean-Marc Classe

18:00
Quelle est la stratégie chirurgicale ?
Pr Pierre Meeus
18:20
Actualités sur la chimiothérapie de première ligne et les stratégies de maintenance
Pr Isabelle Ray-Coquard
18:40
Comment prendre en charge la patiente âgée ?
Pr Claire Falandry
19:00
Discussion/Débat et réponses aux questions

 

Shooting date : 2021-09-15
Last update : 2021-09-28
1 comment
Join the Discussion
  • zouhour B. En cas de rechute Platine sensible quelle est la place de la chirurgie après disparition ss chimiothérapie de la recidive

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
    Honolulu : Wednesday, May 18th 2022 from 07:30am to 09am (GMT+2)
    San Francisco : Wednesday, May 18th 2022 from 10:30am to 12pm (GMT+2)
    New York : Wednesday, May 18th 2022 from 01:30pm to 03pm (GMT+2)
    Buenos Aires : Wednesday, May 18th 2022 from 02:30pm to 04pm (GMT+2)
    Reykjavik : Wednesday, May 18th 2022 from 05:30pm to 07pm (GMT+2)
    London / Dublin : Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
    Paris / Berlin : Wednesday, May 18th 2022 from 07:30pm to 09pm (GMT+2)
    Istanbul : Wednesday, May 18th 2022 from 08:30pm to 10pm (GMT+2)
    Moscou / Dubaï : Wednesday, May 18th 2022 from 09:30pm to 11pm (GMT+2)
    Bangkok : Thursday, May 19th 2022 from 12:30am to 02am (GMT+2)
    Shanghai : Thursday, May 19th 2022 from 01:30am to 03am (GMT+2)
    Tokyo : Thursday, May 19th 2022 from 02:30am to 04am (GMT+2)
    Sydney : Thursday, May 19th 2022 from 04:30am to 06am (GMT+2)
    Wellington : Thursday, May 19th 2022 from 06:30am to 08am (GMT+2)

    Importance de la chimio-sensibilité dans la prise en charge des cancers de l’ovaire

    Share
    Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
    Honolulu : Monday, October 16th 2023 from 07am to 08:30am (GMT+2)
    San Francisco : Monday, October 16th 2023 from 10am to 11:30am (GMT+2)
    New York : Monday, October 16th 2023 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Monday, October 16th 2023 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Monday, October 16th 2023 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Monday, October 16th 2023 from 07pm to 08:30pm (GMT+2)
    Istanbul : Monday, October 16th 2023 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Monday, October 16th 2023 from 09pm to 10:30pm (GMT+2)
    Bangkok : Tuesday, October 17th 2023 from 12am to 01:30am (GMT+2)
    Shanghai : Tuesday, October 17th 2023 from 01am to 02:30am (GMT+2)
    Tokyo : Tuesday, October 17th 2023 from 02am to 03:30am (GMT+2)
    Sydney : Tuesday, October 17th 2023 from 04am to 05:30am (GMT+2)
    Wellington : Tuesday, October 17th 2023 from 06am to 07:30am (GMT+2)

    La nouvelle classification des cancers de l’endomètre en pratique

    Cycle d'enseignement - Les cancers gynécologiques

    Share
    Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, October 10th 2023 from 07:30am to 09am (GMT+2)
    San Francisco : Tuesday, October 10th 2023 from 10:30am to 12pm (GMT+2)
    New York : Tuesday, October 10th 2023 from 01:30pm to 03pm (GMT+2)
    Buenos Aires : Tuesday, October 10th 2023 from 02:30pm to 04pm (GMT+2)
    Reykjavik : Tuesday, October 10th 2023 from 05:30pm to 07pm (GMT+2)
    London / Dublin : Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
    Paris / Berlin : Tuesday, October 10th 2023 from 07:30pm to 09pm (GMT+2)
    Istanbul : Tuesday, October 10th 2023 from 08:30pm to 10pm (GMT+2)
    Moscou / Dubaï : Tuesday, October 10th 2023 from 09:30pm to 11pm (GMT+2)
    Bangkok : Wednesday, October 11th 2023 from 12:30am to 02am (GMT+2)
    Shanghai : Wednesday, October 11th 2023 from 01:30am to 03am (GMT+2)
    Tokyo : Wednesday, October 11th 2023 from 02:30am to 04am (GMT+2)
    Sydney : Wednesday, October 11th 2023 from 04:30am to 06am (GMT+2)
    Wellington : Wednesday, October 11th 2023 from 06:30am to 08am (GMT+2)

    La prise en charge du cancer de l’ovaire chez la personne âgée : expériences croisées du CGFL ...

    Cycle d'enseignement sur le cancer de l'ovaire - Deuxième session

    Share
    Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Thursday, March 14th 2024 from 07am to 08:30am (GMT+1)
    San Francisco : Thursday, March 14th 2024 from 09am to 10:30am (GMT+1)
    New York : Thursday, March 14th 2024 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Thursday, March 14th 2024 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Thursday, March 14th 2024 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
    Istanbul : Thursday, March 14th 2024 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Thursday, March 14th 2024 from 09pm to 10:30pm (GMT+1)
    Bangkok : Friday, March 15th 2024 from 12am to 01:30am (GMT+1)
    Shanghai : Friday, March 15th 2024 from 01am to 02:30am (GMT+1)
    Tokyo : Friday, March 15th 2024 from 02am to 03:30am (GMT+1)
    Sydney : Friday, March 15th 2024 from 03am to 04:30am (GMT+1)
    Wellington : Friday, March 15th 2024 from 05am to 06:30am (GMT+1)

    Prise en charge du cancer de l’ovaire en L1 en région Nord/Normandie : où en sommes-nous ?

    Cycle d'enseignement sur le cancer de l'ovaire - Troisième session

    Share
    Scroll Up